Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

15.44
Delayed Data
As of 4:00pm ET
 +0.28 / +1.85%
Today’s Change
12.56
Today|||52-Week Range
88.54
-74.78%
Year-to-Date
Endo International (ENDP) Marked As A Dead Cat Bounce Stock
May 20 / TheStreet.com - Paid Partner Content
Why Endo International plc Investigated a Lower Price
May 11 / MotleyFool.com - Paid Partner Content
Strong Upward Pre-Market Activity For Endo International (ENDP)
May 17 / TheStreet.com - Paid Partner Content
BioDelivery (BDSI) Posts In-Line Loss in Q1, Revenues Miss
May 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close15.16
Today’s open15.33
Day’s range14.78 - 15.61
Volume6,927,874
Average volume (3 months)8,070,789
Market cap$3.4B
Dividend yield--
Data as of 4:00pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-0.27%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+13.61%
P/E ratioNM
Price/Sales3.69
Price/Book0.56

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...+1.20+0.87%
AKRXAkorn Inc+0.48+1.57%
CBPOChina Biologic Produ...+0.51+0.44%
ACADACADIA Pharmaceutica...+0.65+1.90%
Data as of 4:00pm ET, 05/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.95
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Rajiv De Silva
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs